Another study showed that the gene expression profiles of mononuclear cells from CML patients who achieved complete cytogenetic response after imatinib treatment also indicated the Pten downregulation [34]. The gene discussed is PTEN; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.